Portfolio Advancing Portfolio Screening Program RFP Year2015 Awarded Amount $150,000 DiseaseMalaria InterventionDrug Development Stage Hit Identification Collaboration Partners Daiichi Sankyo RD Novare Co., Ltd., Medicines for Malaria Venture (MMV)